TickerFacts.

A business in context

XERS research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-10-13 · 0001867096-26-000091 · Items 8.01

  2. 4 · Ownership change

    Report date 2026-10-01 · 0001867096-26-000086

  3. 4 · Ownership change

    Report date 2026-10-01 · 0001867096-26-000085

  4. 4 · Ownership change

    Report date 2026-10-01 · 0001867096-26-000084

  5. 4 · Ownership change

    Report date 2026-09-28 · 0001867096-26-000078

  6. 8-K · Current report

    Report date 2026-09-09 · 0001867096-26-000077 · Items 7.01,9.01

  7. 4 · Ownership change

    Report date 2026-09-01 · 0002031695-26-000011

  8. 4 · Ownership change

    Report date 2026-09-01 · 0001875714-26-000012

  9. 4 · Ownership change

    Report date 2026-09-01 · 0001652410-26-000018

  10. 4 · Ownership change

    Report date 2026-08-01 · 0001867096-26-000073

  11. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001867096-26-000065

  12. 8-K · Current report

    Report date 2026-08-06 · 0001867096-26-000063 · Items 2.02,9.01

  13. 8-K · Current report

    Report date 2026-07-15 · 0001867096-26-000055 · Items 3.02,8.01

  14. 8-K · Current report

    Report date 2026-06-29 · 0001867096-26-000048 · Items 5.02,7.01,9.01

  15. 8-K · Current report

    Report date 2026-06-10 · 0001867096-26-000045 · Items 3.02,8.01,9.01

  16. 8-K · Current report

    Report date 2026-06-04 · 0001867096-26-000034 · Items 5.07

  17. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001867096-26-000030

  18. 8-K · Current report

    Report date 2026-05-07 · 0001867096-26-000027 · Items 2.02

  19. DEF 14A · Proxy statement

    Report date 2025-12-31 · 0001867096-26-000021

  20. 8-K · Current report

    Report date 2026-04-20 · 0001867096-26-000020 · Items 5.02

  21. 10-K · Annual report

    Report date 2025-12-31 · 0001867096-26-000016

  22. 8-K · Current report

    Report date 2026-03-02 · 0001867096-26-000012 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2026-02-26 · 0001867096-26-000010 · Items 7.01,9.01

  24. 8-K · Current report

    Report date 2026-01-08 · 0001867096-26-000004 · Items 2.02

  25. 8-K · Current report

    Report date 2025-12-01 · 0001867096-25-000161 · Items 7.01,9.01

  26. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001867096-25-000159

  27. 8-K · Current report

    Report date 2025-11-06 · 0001867096-25-000156 · Items 2.02

  28. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001867096-25-000136

  29. 8-K · Current report

    Report date 2025-08-07 · 0001867096-25-000130 · Items 2.02

  30. 8-K · Current report

    Report date 2025-06-04 · 0001867096-25-000104 · Items 5.07

  31. 8-K · Current report

    Report date 2025-06-03 · 0001867096-25-000100 · Items 7.01,9.01

  32. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001867096-25-000089

  33. 8-K · Current report

    Report date 2025-05-08 · 0001867096-25-000085 · Items 2.02,9.01

  34. DEF 14A · Proxy statement

    Report date 2024-12-31 · 0001867096-25-000068

  35. 8-K · Current report

    Report date 2025-03-28 · 0001867096-25-000054 · Items 5.02,7.01,9.01

  36. 10-K · Annual report

    Report date 2024-12-31 · 0001867096-25-000039

  37. 8-K · Current report

    Report date 2025-03-06 · 0001867096-25-000034 · Items 2.02,9.01

  38. 8-K · Current report

    Report date 2025-02-24 · 0001867096-25-000031 · Items 5.02,7.01,9.01

  39. 8-K · Current report

    Report date 2025-01-10 · 0001867096-25-000017 · Items 2.02,9.01

  40. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001867096-24-000187

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 11 transaction rows11SGrant / award: 2 transaction rows2AExercise / conversion: 0 transaction rows0MTax / exercise payment: 2 transaction rows2FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

15 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-28
2026-09-29
McCulloch Kevin
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock25000.010.0
2026-09-01
2026-09-01
McCulloch Kevin
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock15000.08.49
2026-09-01
2026-09-01
Pieper Steven
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock5000.08.5
2026-09-01
2026-09-01
Hecht Beth
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock16666.08.49
2026-08-12
2026-08-12
Pieper Steven
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock5000.08.5
2026-08-03
2026-08-04
McCulloch Kevin
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock15000.08.02
2026-08-03
2026-08-04
Hecht Beth
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock16666.08.01
2026-08-01
2026-08-21
Shannon John Patrick JrF · Tax / exercise payment
Disposed
Common Stock36645.08.08
2026-08-01
2026-08-21
McCulloch KevinF · Tax / exercise payment
Disposed
Common Stock21918.08.08
2026-07-07
2026-07-07
Pieper Steven
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock27600.08.52
2026-07-06
2026-07-07
Pieper Steven
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock17400.08.5
2026-07-01
2026-07-02
McCulloch Kevin
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock90000.08.03
2026-07-01
2026-07-02
KREHER NERISSAA · Grant / award
Acquired
Common Stock33582.00.0
2026-07-01
2026-07-02
KREHER NERISSAA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
37910.08.0
2026-07-01
2026-07-02
Hecht Beth
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock16666.08.03

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001867096Xeris Biopharma Holdings, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$203.07M$218.12M
    2023-12-31$163.91M$181.25M
    2022-12-31$110.25M$126.91M
    2021-12-31$49.59M$61.65M
    2020-12-31$20.16M$26.24M

    Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

    Explore the CPI history ↗